Key Points

  • After CAR T cell therapy, macrophage activation syndrome-like disorder is identified by rising ferritin, elevated LDH, and low fibrinogen

  • Antecedent infections may predict macrophage activation syndrome-like disorder development

This content is only available as a PDF.

Article PDF first page preview

Article PDF first page preview

Supplemental data